A Comparative Study Of Truscreen vs Pap Smear For Cervical Cancer Screening In General Screening Populatio
- Registration Number
- CTRI/2020/01/022650
- Lead Sponsor
- Khandelwal laboratories Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 645
1. Able to understand the conditions of the trial.
2. Willing and able to sign the patient information sheet and consent form.
1. Under the age of 18 and over the age of 65 years
2.Recent ( <6 weeks) Pap Smear
3.Current menstrual period with heavy flow (days 1-3)
4.Known to be pregnant or less than 4 months post-delivery
5.Received surgical treatment to the cervix (including punch biopsies)
6.Previous hysterectomy (corpus and cervix)
7.Receiving experimental photodynamic therapy or otherwise exposed to photosensitive drugs, or suffering from a photosensitising disease (eg, porphyria, lupus erythematous)
8.Has received radiotherapy treatment in the pelvic region at any time previously
9.Receiving chemotherapy, or has received chemotherapy within the last 5 weeks
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Colposcopy and biopsy outcome <br/ ><br>oPatient Reported satisfaction rate as compared to PAP smear <br/ ><br> <br/ ><br>Timepoint: 3 months, 6 months, 9 months.
- Secondary Outcome Measures
Name Time Method Patient Reported satisfaction rate as compared to PAP smear <br/ ><br>Timepoint: 3 months, 6 months, 9 months.